Cargando…
Expression and up-regulation of interleukin-6 in oesophageal carcinoma cells by n-sodium butyrate
Recently, the serum level of interleukin (IL)-6 has been shown to correlate with disease progression and prognosis of cancer patients. However, the available information about the source and the pathophysiological regulation of IL-6 in cancer cells is limited. Thus, in this study, we tried to identi...
Autores principales: | Wang, L-S, Chow, K-C, Wu, C-W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363087/ https://www.ncbi.nlm.nih.gov/pubmed/10408408 http://dx.doi.org/10.1038/sj.bjc.6690571 |
Ejemplares similares
-
Sodium butyrate enhances STAT 1 expression in PLC/PRF/5 hepatoma cells and augments their responsiveness to interferon-α
por: Hung, W-C, et al.
Publicado: (1999) -
The clinical significance of MMP-1 expression in oesophageal carcinoma
por: Yamashita, K, et al.
Publicado: (2001) -
Expression of interleukin 6 (IL-6) correlates with oestrogen receptor in human breast carcinoma
por: Fontanini, G, et al.
Publicado: (1999) -
Butyrate regulates E-cadherin transcription, isoform expression and intracellular position in colon cancer cells
por: Barshishat, M, et al.
Publicado: (2000) -
Lack of DMBT1 expression in oesophageal, gastric and colon cancers
por: Mori, M, et al.
Publicado: (1999)